Literature DB >> 8370166

Antibody penetration of viable human cells. II. Anti-RNP antibodies binding to RNP antigen expressed on cell surface, which may mediate the antibody internalization.

J Ma1, N King, S L Chen, R Penny, S N Breit.   

Abstract

As U1 small nuclear ribonucleoprotein (U1 snRNP2) has a crucial role in pre-mRNP splicing, the interaction of anti-RNP antibody with snRNP within viable lymphocytes may profoundly influence cell functions. We have shown that antibody can penetrate viable human lymphocytes, and anti-RNP antibodies enter more cells than other anti-nuclear antibodies or control IgG. In order to study the in vitro interaction of anti-RNP antibodies with viable cells, T lymphocytes were metabolically labelled with 35S-methionine, then incubated with the antibodies and washed. A set of 35S-labelled cell-associated snRNP polypeptides A, B'/B, C and D were found to bind to both monospecific human polyclonal anti-RNP IgG (human anti-RNP IgG) and a mouse monoclonal anti-RNP antibody (2.73), indicating that anti-RNP antibodies interacted with RNP antigen inside or/and on the surface of viable cells. To investigate antibody binding to RNP antigen on the cell surface, the cell surface proteins were either iodinated with 125I or the cells processed for immunoelectron microscopic studies after incubation with MoAb. At least seven 125I-labelled polypeptides on the cell surface were found to be immunoprecipitated by the anti-RNP MoAb which have similar molecular weights to U snRNP polypeptides 70K, A, B, D, E, F, and G. The immunoelectron microscopic studies showed that the gold particles formed clustered patches on the cell membrane. Further studies suggested that RNP antigen bound to the cell surface, and the RNP binding structure was probably a heterodimer receptor. This study provides evidence to suggest that anti-RNP antibody entry into viable cells may be mediated by interaction with RNP antigen expressed on the cell surface.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8370166      PMCID: PMC1554925          DOI: 10.1111/j.1365-2249.1993.tb08191.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  37 in total

Review 1.  Antibodies to snRNPs in systemic lupus erythematosus.

Authors:  J Craft
Journal:  Rheum Dis Clin North Am       Date:  1992-05       Impact factor: 2.670

2.  Antibody penetration into living cells. II. Anti-ribonucleoprotein IgG penetrates into Tgamma lymphocytes causing their deletion and the abrogation of suppressor function.

Authors:  D Alarcon-Segovia; A Ruiz-Arguelles; L Llorente
Journal:  J Immunol       Date:  1979-05       Impact factor: 5.422

3.  Assays for the Sm and RNP autoantigens: the requirement for RNA and influence of the tissue source.

Authors:  P J White; P B Billings; S O Hoch
Journal:  J Immunol       Date:  1982-06       Impact factor: 5.422

4.  Anti-RNP monoclonal antibodies derived from a mouse strain with lupus-like autoimmunity.

Authors:  P B Billings; R W Allen; F C Jensen; S O Hoch
Journal:  J Immunol       Date:  1982-03       Impact factor: 5.422

5.  Antibody penetration into living cells. III. Effect of antiribonucleoprotein IgG on the cell cycle of human peripheral blood mononuclear cells.

Authors:  D Alarcon-Segovia; L Llorente; A Ruiz-Arguelles
Journal:  Clin Immunol Immunopathol       Date:  1982-04

6.  Antibodies to small nuclear RNAs complexed with proteins are produced by patients with systemic lupus erythematosus.

Authors:  M R Lerner; J A Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

7.  Antibody penetration into living cells. I. Intranuclear immunoglobulin in peripheral blood mononuclear cells in mixed connective tissue disease and systemic lupus erythematosus.

Authors:  D Alarcón-Segovia; A Ruíz-Argüelles; E Fishbein
Journal:  Clin Exp Immunol       Date:  1979-03       Impact factor: 4.330

8.  Antibody penetration into living cells. V. Interference between two fc gamma receptor-mediated functions: antibody penetration and antibody-dependent cellular cytotoxicity.

Authors:  J M Llerena; A Ruíz-Argüelles; D Alarcón-Segovia; L Llorente; E Díaz-Jouanen
Journal:  Immunology       Date:  1981-06       Impact factor: 7.397

9.  The subunit structure of the high affinity insulin receptor. Evidence for a disulfide-linked receptor complex in fat cell and liver plasma membranes.

Authors:  P F Pilch; M P Czech
Journal:  J Biol Chem       Date:  1980-02-25       Impact factor: 5.157

10.  Role of coated vesicles, microfilaments, and calmodulin in receptor-mediated endocytosis by cultured B lymphoblastoid cells.

Authors:  J L Salisbury; J S Condeelis; P Satir
Journal:  J Cell Biol       Date:  1980-10       Impact factor: 10.539

View more
  4 in total

1.  Up-regulation of intercellular adhesion molecule-1 (ICAM-1), endothelial leucocyte adhesion molecule-1 (ELAM-1) and class II MHC molecules on pulmonary artery endothelial cells by antibodies against U1-ribonucleoprotein.

Authors:  M Okawa-Takatsuji; S Aotsuka; M Fujinami; S Uwatoko; M Kinoshita; M Sumiya
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

2.  Enhanced synthesis of cytokines by peripheral blood monocytes cultured in the presence of autoantibodies against U1-ribonucleoprotein and/or negatively charged molecules: implication in the pathogenesis of pulmonary hypertension in mixed connective tissue disease (MCTD).

Authors:  M Okawa-Takatsuji; S Aotsuka; S Uwatoko; M Sumiya; R Yokohari
Journal:  Clin Exp Immunol       Date:  1994-12       Impact factor: 4.330

3.  DNA-histone complexes as ligands amplify cell penetration and nuclear targeting of anti-DNA antibodies via energy-independent mechanisms.

Authors:  Markella Zannikou; Sofia Bellou; Petros Eliades; Aikaterini Hatzioannou; Michael D Mantzaris; George Carayanniotis; Stratis Avrameas; Peggy Lymberi
Journal:  Immunology       Date:  2015-11-24       Impact factor: 7.397

4.  An Exploration of the Impact of Anticentromere Antibody on Early-Stage Embryo.

Authors:  Ying Ying; Xi Guo; Yiping Zhong; Canquan Zhou
Journal:  J Immunol Res       Date:  2017-10-04       Impact factor: 4.818

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.